ExoLuminate is a nationally-enrolling registry study designed for earlier detection of cancer in patients at elevated risk or clinically-suspicious for pancrea…

Pancreas CancerExosomesExtracellular Vesicles+1 more

~Estimated

~$10 – $1,125

Biological DynamicsNCT05625529

Phase 1

An Open-label and Dose-escalation Phase I Clinical Study to Evaluate the Tolerability, Safety, and Pharmacokinetics of HLA-G-targeted Exosome (SOB100) in Healthy Subjects

The investigational drug, SOB100, is an HLA-G targeted exosome equipped with a nanobody namely anti-HLA-G VHH on the exosome membrane. This is a Phase I dose e…

Healthy SubjectsExosomeTargeted Therapy

~Estimated

~$10 – $8,750

Shine-On Biomedical Co., Ltd.NCT07219940